Samsung Medical Center
🇰🇷South Korea
- Country
- 🇰🇷South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
The Benefit of Prophylactic Anticonvulsant in Post Cardiac Arrest Syndrome With Induced Mild Hypothermia
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2011-07-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01083784
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2014-05-14
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 59
- Registration Number
- NCT01082809
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study
Phase 2
Completed
- Conditions
- First Posted Date
- 2010-03-09
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 36
- Registration Number
- NCT01083342
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Combination Anticancer Therapy of Paclitaxel and Everolimus for Relapsed or Refractory Small Cell Lung Cancer
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 21
- Registration Number
- NCT01079481
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Endobronchial Ultrasound- Transbronchial Needle Aspiration (EBUS-TBNA) Versus Mediastinoscopy for Mediastinal Lymph Node Staging of Non-small Cell Lung Cancer (NSCLC)
Not Applicable
Completed
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 138
- Registration Number
- NCT01079520
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Genome-wide Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Lymphoblastic Leukemia
- Conditions
- First Posted Date
- 2010-03-03
- Last Posted Date
- 2010-03-03
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 200
- Registration Number
- NCT01079507
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based Chemotherapy
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2010-02-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 129
- Registration Number
- NCT01066195
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Adjuvant CCRT vs CT in Minimal N2 NSCLC
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2021-03-22
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 17
- Registration Number
- NCT01066234
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Genome-wide Pharmacogenetic Candidate Gene Single Nucleotide Polymorphism (SNP) Array-based Approach to Predict Chemoresponse and Survival in Patients With Acute Myeloid Leukemia With Normal Karyotype
- Conditions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2010-02-19
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 500
- Registration Number
- NCT01066338
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
Genome Wide SNP Array-based Approach to Detect Micro-cytogenetic Lesions and KIT Mutation to Improve Treatment Outcomes in Patients With Core-binding Factor Positive Acute Myeloid Leukemia
- Conditions
- First Posted Date
- 2010-02-10
- Last Posted Date
- 2010-02-10
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 100
- Registration Number
- NCT01066286
- Locations
- 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
© Copyright 2024. All Rights Reserved by MedPath